BMRN BioMarin Pharmaceutical Inc.

BMRN BioMarin Pharmaceutical Inc.

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-10-16 1 neutral converging

POC $54.24 · VWAP $57.66 · -5.2% vs 12m avg buyer

pullback vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

BMRN Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist BMRN belongs to, members best 30-day change first — BMRN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings BMRN reports in 9 days Oct 26

Last report Aug 6

Reported the quarter ending 2026-06-30: revenue $990M, diluted EPS $0.23, net income $45M (SEC filing). Across the print the stock moved +6.5% (close before → first close after).

full note →

Against street estimates

How BMRN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 6 · projection Oct 16

Result
Aug 6 0.951.20 GAAP ≠ +25.8%Beat
May 4 0.910.76 GAAP ≠ -16.9%Miss
Feb 23 0.560.46-17.9%Miss
Oct 27 '25 0.340.12 GAAP ≠ -64.3%Miss
Aug 4 '25 1.031.44+39.4%Beat
May 1 '25 0.951.13+18.6%Beat
Feb 19 '25 0.740.92+24.6%Beat
Oct 29 '24 0.790.91 GAAP ≠ +14.7%Beat

Recent news

Headlines about BMRN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 8 days ago · Oct 9

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Aug 6 Catalyst BMRN earnings
Aug 3 Catalyst BMRN earnings
Mar 24 Article Daily Actions